Stock Price Movement and Market Context
On 28 Jan 2026, Poly Medicure Ltd’s share price declined by 0.18% on the day, aligning with the overall sector’s performance. However, the stock has been on a downward trajectory for three consecutive sessions, resulting in a cumulative loss of 6.12% over this period. This recent slide has pushed the stock below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.
In contrast, the broader market displayed resilience. The Sensex opened flat but surged to close 344.50 points higher at 82,236.86, a 0.46% gain. Despite this, the Sensex remains 4.77% shy of its 52-week high of 86,159.02. Mega-cap stocks led the rally, while Poly Medicure’s performance lagged notably behind.
Long-Term Performance and Valuation Metrics
Over the past year, Poly Medicure Ltd has underperformed significantly, delivering a negative return of 33.01%, compared to the Sensex’s positive 8.35% and the BSE500’s 9.20% gains. Despite this, the company’s profits have increased by 22.8% during the same period, indicating a disconnect between earnings growth and share price performance.
The stock’s valuation remains elevated, with a price-to-book value of 5.3 and a return on equity (ROE) of 12.4%. The PEG ratio stands at 1.9, suggesting the market is pricing in growth but at a premium relative to earnings expansion. This valuation is considered very expensive when compared to peers, although the current share price trades at a discount to the company’s historical averages.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Financial Ratios and Dividend Profile
Poly Medicure’s dividend payout ratio (DPR) is notably low at 10.70%, reflecting a conservative approach to shareholder returns. The company’s debtors turnover ratio for the half-year period stands at 4.02 times, the lowest among its recent historical figures, indicating slower collection cycles. On the positive side, the company maintains a negligible debt-to-equity ratio, averaging zero, which underscores a strong balance sheet with minimal leverage.
Sector Position and Market Capitalisation
With a market capitalisation of approximately Rs 15,383 crores, Poly Medicure Ltd is the second-largest company in the healthcare services sector, representing 14.92% of the sector’s total market value. It trails only Lenskart Solutions in size. The company’s annual sales of Rs 1,712.13 crores account for 15.86% of the industry’s revenue, highlighting its significant presence within the sector.
Institutional Holdings and Market Sentiment
Institutional investors hold a substantial 23.24% stake in Poly Medicure Ltd. These investors typically possess greater analytical resources and a longer-term perspective on company fundamentals. Despite this, the stock’s recent price action suggests prevailing caution or profit-taking among market participants.
Poly Medicure Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Recent Earnings and Market Grade Changes
The company reported flat results in the September 2025 quarter, which contributed to a downgrade in its Mojo Grade from Hold to Sell on 28 May 2025. The current Mojo Score stands at 37.0, reflecting a cautious outlook based on recent financial and market performance. The market cap grade is rated at 3, indicating a mid-tier valuation relative to market capitalisation benchmarks.
Summary of Price and Performance Indicators
Poly Medicure’s 52-week high was Rs 2,936.70, reached within the last year, contrasting sharply with the current 52-week low of Rs 1,501.75. This represents a decline of nearly 49% from its peak. The stock’s sustained fall over recent sessions and its position below all major moving averages highlight the prevailing downward trend.
While the broader market and sector have shown resilience, Poly Medicure’s share price has not mirrored this strength, reflecting specific company-level factors and valuation concerns. The company’s strong balance sheet and profit growth have not translated into share price gains, underscoring the complex dynamics influencing investor sentiment.
Unlock special upgrade rates for a limited period. Start Saving Now →
